Literature DB >> 17368207

Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy.

David A Mankoff1, Finbarr O'Sullivan, William E Barlow, Kenneth A Krohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17368207      PMCID： PMC1868571          DOI： 10.1016/j.acra.2007.01.005

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  43 in total

1.  Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.

Authors:  Kevin S Tralins; James G Douglas; Keith J Stelzer; David A Mankoff; Daniel L Silbergeld; Robert C Rostomily; Sharon Hummel; Jeff Scharnhorst; Kenneth A Krohn; Alexander M Spence; Robert Rostomilly
Journal:  J Nucl Med       Date:  2002-12       Impact factor: 10.057

Review 2.  Use of positron emission tomography in anticancer drug development.

Authors:  Eric O Aboagye; Patricia M Price
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

Review 3.  The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Authors:  Y Yarden
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

4.  [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.

Authors:  David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Erin K Schubert; Aaron W Charlop; Jeffrey Tseng; Kristine J Rinn; Robert B Livingston
Journal:  Nucl Med Biol       Date:  2002-10       Impact factor: 2.408

5.  Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.

Authors:  J E Mortimer; F Dehdashti; B A Siegel; K Trinkaus; J A Katzenellenbogen; M J Welch
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

Review 6.  New targeted therapies in breast cancer.

Authors:  Virginia Kaklamani; Ruth M O'Regan
Journal:  Semin Oncol       Date:  2004-04       Impact factor: 4.929

7.  18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

Authors:  S Stroobants; J Goeminne; M Seegers; S Dimitrijevic; P Dupont; J Nuyts; M Martens; B van den Borne; P Cole; R Sciot; H Dumez; S Silberman; L Mortelmans; A van Oosterom
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

8.  Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.

Authors:  Farrokh Dehdashti; Perry W Grigsby; Mark A Mintun; Jason S Lewis; Barry A Siegel; Michael J Welch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-04-01       Impact factor: 7.038

9.  Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.

Authors:  Janet F Eary; Finbarr O'Sullivan; Yudi Powitan; Kingshuk Roy Chandhury; Cheryl Vernon; James D Bruckner; Ernest U Conrad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-19       Impact factor: 9.236

10.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G C Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G J Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640
View more
  11 in total

1.  VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLES.

Authors:  Finbarr O'Sullivan; Mark Muzi; David A Mankoff; Janet F Eary; Alexander M Spence; Kenneth A Krohn
Journal:  Ann Appl Stat       Date:  2014-06-01       Impact factor: 2.083

2.  3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.

Authors:  Kamiar Moin; Mansoureh Sameni; Bernadette C Victor; Jennifer M Rothberg; Raymond R Mattingly; Bonnie F Sloane
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

3.  Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.

Authors:  Albert E Cerussi; Vaya W Tanamai; Rita S Mehta; David Hsiang; John Butler; Bruce J Tromberg
Journal:  Acad Radiol       Date:  2010-06-12       Impact factor: 3.173

Review 4.  Image-guided nanosystems for targeted delivery in cancer therapy.

Authors:  A K Iyer; J He; M M Amiji
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 5.  Development of Companion Diagnostics.

Authors:  David A Mankoff; Christine E Edmonds; Michael D Farwell; Daniel A Pryma
Journal:  Semin Nucl Med       Date:  2016-01       Impact factor: 4.446

6.  PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Authors:  Paul E Kinahan; Robert K Doot; Michelle Wanner-Roybal; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Geoffrey McLennan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

Review 7.  Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

Authors:  Austin R Pantel; David A Mankoff
Journal:  Cancer Lett       Date:  2016-05-16       Impact factor: 8.679

Review 8.  Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.

Authors:  John Kurhanewicz; Daniel B Vigneron; Jan Henrik Ardenkjaer-Larsen; James A Bankson; Kevin Brindle; Charles H Cunningham; Ferdia A Gallagher; Kayvan R Keshari; Andreas Kjaer; Christoffer Laustsen; David A Mankoff; Matthew E Merritt; Sarah J Nelson; John M Pauly; Philips Lee; Sabrina Ronen; Damian J Tyler; Sunder S Rajan; Daniel M Spielman; Lawrence Wald; Xiaoliang Zhang; Craig R Malloy; Rahim Rizi
Journal:  Neoplasia       Date:  2018-11-23       Impact factor: 5.715

Review 9.  Molecular imaging as a tool for translating breast cancer science.

Authors:  David A Mankoff
Journal:  Breast Cancer Res       Date:  2008-12-09       Impact factor: 6.466

10.  The contribution of physics to Nuclear Medicine: physicians' perspective on future directions.

Authors:  David A Mankoff; Daniel A Pryma
Journal:  EJNMMI Phys       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.